BCL9 anticorps (N-Term)

N° du produit ABIN5672386

Cet anticorps Lapin Polyclonal détecte spécifiquement BCL9 dans WB. Il présente une réactivité envers Humain.

Aperçu rapide pour BCL9 anticorps (N-Term) (ABIN5672386)

Antigène: BCL9 (B-Cell CLL/lymphoma 9 (BCL9))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCL9 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-BCL9 anticorps

Épitope: N-Term

Séquence: NGAKGKGKRE RSISADSFDQ RDPGTPNDDS DIKECNSADH IKSQDSQHTP

Purification: Affinity purified

Immunogène: The immunogen is a synthetic peptide directed towards the N terminal region of human BCL9

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Détails sur BCL9

Antigène: BCL9 (B-Cell CLL/lymphoma 9 (BCL9))

Autre désignation: BCL9

Sujet: BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

Alias Symbols: LGS

Protein Size: 1426

ID gène: 607

NCBI Accession: NM_004326, NP_004317

UniProt: O00512

Pathways: Stem Cell Maintenance